Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Risk”

970 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 970 results

Testing effectiveness (Phase 2)Study completedNCT02729701
What this trial is testing

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Who this might be right for
Breast Cancer
University of Kansas Medical Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65
Very early researchActive Not RecruitingNCT04674306
What this trial is testing

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Who this might be right for
Pathologic Stage IIA-IIIC Triple-Negative Breast CancerTNBC - Triple-Negative Breast CancerResidual Disease
George T. Budd 35
Testing effectiveness (Phase 2)Looking for participantsNCT06845319
What this trial is testing

Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Medical University of South Carolina 43
Not applicableWithdrawnNCT02574546
What this trial is testing

Markers for Predicting Risk of Breast Cancer in Women of Different Races

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Active Not RecruitingNCT03595592
What this trial is testing

Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer

Who this might be right for
Invasive Breast Cancer
Fondazione Michelangelo 650
Not applicableNot Yet RecruitingNCT06076772
What this trial is testing

Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Assiut University 54
Not applicableActive Not RecruitingNCT04541212
What this trial is testing

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

Who this might be right for
Breast CancerLymphomaLeukemia
Montreal Heart Institute 169
Not applicableStudy completedNCT00544167
What this trial is testing

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 45
Not applicableStudy completedNCT05796219
What this trial is testing

Automated Low Dose Risk Assessment Mammography (ALDRAM)

Who this might be right for
Breast Cancer
Manchester University NHS Foundation Trust 154
Not applicableStudy completedNCT00892515
What this trial is testing

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast CancerHealthy, no Evidence of Disease
Abramson Cancer Center at Penn Medicine 183
Testing effectiveness (Phase 2)Ended earlyNCT01276704
What this trial is testing

Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 180
Not applicableUnknownNCT03080155
What this trial is testing

Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer

Who this might be right for
Breast Cancer
Real Imaging Ltd. 680
Not applicableUnknownNCT03383835
What this trial is testing

Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Lauren Nye 11
Not applicableStudy completedNCT00897416
What this trial is testing

Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer

Who this might be right for
Breast Cancer
Fred Hutchinson Cancer Center 1,452
Not applicableUnknownNCT04821609
What this trial is testing

Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema

Who this might be right for
Breast CancerPhysical ActivityLymphedema of Upper Arm
Pontificia Universidad Catolica de Chile 106
Early research (Phase 1)Study completedNCT00841399
What this trial is testing

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

Who this might be right for
Breast Cancer
COL George Peoples, MD, FACS 100
Not applicableStudy completedNCT03800355
What this trial is testing

Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk

Who this might be right for
Breast Cancer, Male
Spanish Breast Cancer Research Group 777
Large-scale testing (Phase 3)UnknownNCT00003678
What this trial is testing

Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Birmingham 20,000
Large-scale testing (Phase 3)Active Not RecruitingNCT00070564
What this trial is testing

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 3,294
Load More Results